e-learning
resources
Milan 2017
Monday, 11.09.2017
Experimental PH
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Proangiogenic and wound healing molecular and histological fingerprint of chronic thromboembolic pulmonary hypertension
D. Iloska (Bad Nauheim, Germany)
Source:
International Congress 2017 – Experimental PH
Session:
Experimental PH
Session type:
Thematic Poster
Number:
2369
Disease area:
Pulmonary vascular diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
D. Iloska (Bad Nauheim, Germany). Proangiogenic and wound healing molecular and histological fingerprint of chronic thromboembolic pulmonary hypertension. 2369
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
The definition of pulmonary hypertension: history, practical implications and current controversies
Should we screen for hereditary pulmonary hypertension?
Patient with ankylosing spondylitis and pulmonary hypertension
Related content which might interest you:
Contribution of inflammation and impaired angiogenesis to the pathobiology of chronic thromboembolic pulmonary hypertension
Source: Eur Respir J 2015; 46: 431-443
Year: 2015
Risk factors and basic mechanisms of chronic thromboembolic pulmonary hypertension: a current understanding
Source: Eur Respir J 2013; 41: 462-468
Year: 2013
Comprehensive analysis of inflammatory markers in chronic thromboembolic pulmonary hypertension patients
Source: Eur Respir J 2014; 44: 951-962
Year: 2014
Microvascular disease in chronic thromboembolic pulmonary hypertension: a role for pulmonary veins and systemic vasculature
Source: Eur Respir J 2014; 44: 1275-1288
Year: 2014
Is inflammation a potential therapeutic target in chronic thromboembolic pulmonary hypertension?
Source: Eur Respir J 2014; 44: 842-845
Year: 2014
The impact of immediate postoperative pulmonary vascular resistance on survival in patients with chronic thromboembolic pulmonary hypertension
Source: Annual Congress 2009 - Pulmonary embolism
Year: 2009
Surgical and post-operative treatment of chronic thromboembolic pulmonary hypertension
Source: Eur Respir Rev 2009; 19: 64-67
Year: 2010
Genetic diagnostics in patients with chronic thromboembolic pulmonary hypertension
Source: International Congress 2019 – Novel methods, diagnostics and biomarkers in chronic lung diseases
Year: 2019
A roadmap for management of chronic thromboembolic pulmonary hypertension
Source: Eur Respir J, 54 (4) 1901295; 10.1183/13993003.01295-2019
Year: 2019
Inflammatory cell accumulation in pulmonary arteries is associated with systemic inflammation in patients with chronic thromboembolic pulmonary hypertension (CTEPH)
Source: Annual Congress 2010 - Pulmonary venous thromboembolic disease
Year: 2010
Predicting recurrent pulmonary embolism and chronic thromboembolic pulmonary hypertension: one more way to skin the cat
Source: Eur Respir J, 49 (5) 1700413; 10.1183/13993003.00413-2017
Year: 2017
Lung cavitation in chronic thromboembolic pulmonary hypertension
Source: Eur Respir J 2005; 26: Suppl. 49, 520s
Year: 2005
Peculiarities of chronic thromboembolic pulmonary hypertension
Source: Eur Respir J 2002; 20: Suppl. 38, 236s
Year: 2002
Chronic thromboembolic pulmonary hypertension
Source: Annual Congress 2007 - Update on venous thromboembolism
Year: 2007
Pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension: pathophysiology
Source: Eur Respir Rev 2009; 19: 59-63
Year: 2010
Plasma metabolomics in chronic thromboembolic pulmonary hypertension
Source: Virtual Congress 2020 – Chronic thromboembolic pulmonary hypertension
Year: 2020
Improved survival in medically-treated chronic thromboembolic pulmonary hypertension
Source: Annual Congress 2011 - Treatment of human pulmonary hypertension
Year: 2011
ERS statement on chronic thromboembolic pulmonary hypertension
Source: ERS webinar 2021: ERS statement on chronic thromboembolic pulmonary hypertension
Year: 2021
The changing landscape of chronic thromboembolic pulmonary hypertension management
Source: Eur Respir Rev, 26 (146) 170105; 10.1183/16000617.0105-2017
Year: 2017
Altered gut microbiota in chronic thromboembolic pulmonary hypertension
Source: Virtual Congress 2021 – Pathogenesis and pathophysiology of pulmonary hypertension
Year: 2021
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept